The effect of low intensity ultraviolet-c light on monoclonal antibodies

Biotechnology Progress

Volumn 25, Issue 2, 2009, Pages 476-482

  Lorenz, Christopher M ^a   Wolk, Bradley M ^a   Quan, Cynthia P ^a   Alcala, Emily W ^a   Eng, Marian ^a   McDonald, Daniel J ^a   Matthews, Timothy C ^a  

^a GENENTECH INC   (United States)

Author keywords

Monoclonal antibodies; Ultraviolet C light; Viral inactivation

Indexed keywords

AGGREGATE FORMATION; CATALYTIC SPECIES; LOW LEVEL; LOW-INTENSITY; METHIONINE OXIDATION; MINIMAL DAMAGE; PRODUCT QUALITY DATA; TECHNOLOGY SERVICE; ULTRAVIOLET-C LIGHT; VIRAL INACTIVATION; VIRAL REDUCTION; VIRUS INACTIVATION;

AGGREGATES; AMINES; PROTEINS; SURFACE PLASMON RESONANCE;

MONOCLONAL ANTIBODIES;

IMMUNOGLOBULIN G; METHIONINE; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CHEMISTRY; CHO CELL; CRICETULUS; HAMSTER; OXIDATION REDUCTION REACTION; PROTEIN CONFORMATION; RADIATION EXPOSURE; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, RADIATION; IMMUNOGLOBULIN G; METHIONINE; OXIDATION-REDUCTION; PROTEIN CONFORMATION; ULTRAVIOLET RAYS;

EID: 66149175809     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.157     Document Type: Article

References (24)

1. Lie YS, Punuel EM, Low ML, Nguyen TP, Mangahas JO, Anderson KP, Petropoulos CJ. Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses. J Virol. 1994;68:7840-7849.
2. Garnick RL. Raw materials as a source of contamination in large-scale cell culture. Dev Biol Stand. 1998;93:21-29.
3. Curtis S, Lee K, Blank G, Brorson K, Xu Y. Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow-through mode. Biotechnol Bioeng. 2003;84:179-186.
4. Cai K, Gierman TM, Hotta J, Stenland CJ, Lee DC, Pifat DY, Petteway SR. Ensuring the biologic safety of plasma-derived therapeutic proteins. Biodrugs. 2005;19:79-96.
5. Phillips M, Cormier J, Ferrence J, Dowd C, Kiss R, Lutz H, Carter J. Performance of a membrane adsorber for trace impurity removal in biotechnology manufacturing. J. Chromatogr A. 2005;1078:74-82.
6. Hongo-Hirasaki T, Yamaguchi K, Yanagida K, Okuyama K. Removal of small viruses (parvovirus) from IgG solution by virus removal filter Planova 20N. J Membr Sci. 2006;278:3-9.
7. van Reis R, Zydney R. Bioprocess membrane technology. J Membr Sci. 2007;297:16-50.
8. Farshid M, Taffs RE, Scott D, Asher DM, Brorson K. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals. Curr Opin Biotechnol. 2005;16:561-567.
9. Rauth AM. The physical state of viral nucleic acid and the sensitivity of viruses to ultraviolet light. Biophys J. 1965;5:257-273.
10. Budowsky EI, Bresler SE, Friedman EA, Zheleznova NV. Principles of selective inactivation of viral genome. I. UV-induced inactivation of influenza virus. Arch Virol. 1981;68:239-247.
11. Kallenbach NR, Cornelius PA, Negus D, Montgomerie D, Englander S. Inactivation of viruses by ultraviolet light. Curr Stud Hematol Blood Transfus. 1989;56:70-82.
12. Caillet-Fauquet P, di Giambattista M, Draps M-L, Sandras F, Branckaert T, de Launoit Y, Laub R. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19. J Virol Methods. 2004;118:131-139.
13. MacLeod AJ. UV-C irradiation of human albumin solution on manufacturing scale. Dev Biol (Basel). 2004;118:139-147.
14. Wang J, Mauser A, Chao S-F, Remington K, Treckmann R, Kaiser K, Pifat D, Hotta J. Virus inactivation and protein recovery in a novel ultraviolet-C reactor. Vox Sang. 2004;86:230-238.
15. Li Q, MacDonald S, Bienek C, Foster PR, MacLeod AJ. Design of a UV-C irradiation process for the inactivation of viruses in protein solutions. Biologicals. 2005;33:101-110.
16. Lytle C, Sagripanti J. Predicted inactivation of viruses of relevance to biodefense by solar radiation. J Virol. 2005;79:14244-14252.
17. Simonet J, Gantzer C. Inactivation of poliovirus 1 and F-specific RNA phages and degradation of their genomes by UV irradiation at 254 nanometers. Appl Environ Microbiol. 2006;72:7671-7677.
18. Mitchell DL. The relative cytotoxicity of (6-4). photoproducts and cyclobutane dimers in mammalian cells. Photochem Photobiol. 1988;48:51-57.
19. Bennett CJ, Webb M, Willer DO, Evans DH. Genetic and phylogenetic characterization of the type II cyclobutane pyrimidine dimer photolyases encoded by Leporipoxviruses. Virology. 2003;315:10-19.
20. Davies MJ. Reactive species formed on proteins exposed to singlet oxygen. Photochem Photobiol Sci. 2004;3:17-25.
21. Chan H-L, Gaffney PR, Waterfield MD, Anderle H, Matthiessen HP, Schwarz HP, Turecek PL, Timms JF. Proteomic analysis of UVC irradiation-induced damage of plasma proteins: serum amyloid P component as a major target of photolysis. FEBS Lett. 2006;3229-3236.
22. Chin S, Williams B, Gottlieb P, Margolis-Nunno H, Ben-Hur E, Hamman J, Jin R, Dubovi E, Horowitz B. Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants. Blood. 1995;86:4331-4336.
23. Marx G, Mou X, Freed R, Ben-Hur E, Yang C, Horowitz B. Protecting fibrinogen with rutin during UVC irradiation for viral inactivation. Photochem Photobiol. 1996;63:541-546.
24. Schmidt S, Kauling J. Process and laboratory scale UV inactivation of viruses and bacteria using an innovative coiled tube reactor. Chem Eng Technol. 2007;30:945-950.